Zantac / Ranitidine (NDMA Cancer) Attorney in Columbus, Ohio

Preparing your case review…
Columbus Data

Zantac / Ranitidine (NDMA Cancer) Statistics in Columbus

~2.1 million

Columbus Metro Population

~200

Est. Annual Bladder Cancer Diagnoses (Franklin County)

2 years from discovery (Daubert)

OH SOL

~30,000 state employees in Columbus area

State Government Employment

Local Courts

Courts in Columbus, Ohio

Franklin County Court of Common Pleas

369 S High St, Columbus, OH 43215

U.S. District Court, Southern District of Ohio — Eastern Division

85 Marconi Blvd, Columbus, OH 43215

Medical Facilities

Hospitals & Trauma Centers in Columbus

The James Comprehensive Cancer Center (Ohio State University)

460 W 10th Ave, Columbus, OH 43210

OhioHealth Oncology — Riverside Methodist Hospital

3535 Olentangy River Rd, Columbus, OH 43214

Liability Overview

Liability Considerations in Columbus

Zantac Litigation in Columbus

Columbus-area Zantac claimants have access to The James — one of the nation's premier NCI-designated cancer centers — for both treatment and documentation of cancer diagnoses. Ohio applies Daubert under Ohio R. Evid. 702. Given the federal MDL's Daubert dismissal, Columbus-area claimants should consult counsel about filing in the Delaware Superior Court, where Judge Medinilla has allowed Zantac causation experts to proceed. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Columbus Zantac Claimants

Columbus-area Zantac claimants should gather pharmacy records from Kroger, Giant Eagle, CVS, and Walgreens. The James Cancer Center at OSU records documenting bladder, esophageal, stomach, or colorectal cancer diagnosis, staging, and treatment are critical. Ohio's 2-year SOL applies from discovery of the diagnosis and its potential Zantac link.